Skip to main content

Peer Review reports

From: FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFκB pathway

Original Submission
30 Oct 2018 Submitted Original manuscript
2 Jan 2019 Reviewed Reviewer Report - Xiangmin Tong
13 Feb 2019 Reviewed Reviewer Report - Reviewer 2
23 Apr 2019 Author responded Author comments - Xiaorong Liu
Resubmission - Version 2
23 Apr 2019 Submitted Manuscript version 2
8 May 2019 Reviewed Reviewer Report - Reviewer 2
14 Jun 2019 Reviewed Reviewer Report - Reviewer 3
25 Jun 2019 Author responded Author comments - Xiaorong Liu
Resubmission - Version 3
25 Jun 2019 Submitted Manuscript version 3
27 Jun 2019 Author responded Author comments - Xiaorong Liu
Resubmission - Version 4
27 Jun 2019 Submitted Manuscript version 4
Publishing
2 Jul 2019 Editorially accepted
10 Jul 2019 Article published 10.1186/s12885-019-5898-4

You can find further information about peer review here.

Back to article page